Home  l  About Us  l  My Account  l  MDA / MAI Schemes  l  Feedback  l  FAQ's  l  Contact Us  l  Photo Gallery  l  Blogs  


Download Acrobat Reader

 
Conferences / Presentations
 
Presentations by Pharmexcil (FMO*)
   
 
Date Forums Subjects Presentation By
       
11.02.2008
PHARMEXCIL India-Asean Business Meet
11.02.2008   India-Asean Business Meet
       
28.11.2007
PHARMEXCI Seminar on DGFT, Forex Risk Management, IPRs & 3rd AGM  
28.11.2007   Indian Patents Law
Dr. Vivekanandan - NALSAR
28.11.2007   IPR Cells – Pharmexcil Role & Services’
Dr. Gopakumar Nair - IPRs
28.11.2007   Forex Risk Management Mr. Kalyan – ICICI, Hyderabad
25.11.2007 PHARMEXCIL

CPhI India 2007 – On the Inaugural Session

Mr.Smitesh Shah, Managing Director, Calyx Chemicals & Pharmaceuticals Ltd.

       
26.10.2007
PHARMEXCIL & Dept. of AYUSH AROGYA 2007- International Meet of TM Regulators and Industry  
26.10.2007   ASU Global Scenario Mr.Venkat Jasti, Vice Chairmen , Pharmexcil
26.10.2007   AYUSH Policy Framework Ms.Anita Das
26.10.2007   Indian Traditional Sciences of Health Prof Dr R H Singh, Proffesor EMERITUS, Bhu
26.10.2007   Ayurvedic Panchkarma Treatment

Dr P R Ramesh, C.M.O Kottakal arya vaidyasala

    TECHNICAL SESSION-I  
27.10.2007   Reverse Pharmacology & Registration of Ayurvedic Drugs Dr A B Vaidya, Chair men, Pharmexcil Mdicinal Plants commette
27.10.2007   Indian Central Drug Authority Mr.Debashish Panda
27.10.2007   Regulatory Aspects of Herbal Medicines in Nepal Mr.Radha Raman Prasad, chef drug administrator, MOHB
27.10.2007   An Overview of IM Pharmaceutical Sector in Sri Lanka Dr. Danister Perera, Registrar, Sri Lanka council of Iron
27.10.2007   Development of Traditional Medicines in Malaysia Ms.Anis Talib,National pharmacetical Control Euro
27.10.2007   Traditional Medicines in Indonesia Dr.Niniek Soedijani, Director , Evaluation of Traditional, food suppliment and cosmatic
    TECHNICAL SESSION-II  
27.10.2007   Possibilities of Licensing/Registration of Medicinal Products from Indian Traditional Medicines in Europe PD Dr. Werner Knöss, Head of the department CAM&TM, Federal Institute for drug and medical devites.
27.10.2007   Market opportunities for Ayurveda in Central & Eastern-Europe(Hungary) Dr. I. J. Riesz, Chaimen, Hunearian Ayuvarda Medical Foundation
27.10.2007   The Italian National Health Service, the CISMO and Ayurveda Medicine Prof.Francesco Donato, Professor , Univercity of BRESCIA, Bre
27.10.2007   Complimentary Medicine in Latvia Prof.Nikolajs Nikolajevs, President ICMARD
    TECHNICAL SESSION  
28.10.2007   Evidence Base of Ayurveda Dr N Srikant, Asst. Director , central confil for research in ayurveda siddha
28.10.2007   Market Opportunities for TM in Europe & North America Dr.Deepika Guanawant, Dabur India Limeted
28.10.2007   Ayurveda-Activities in Czech Republic Dr.George Essay, Chirmen, the CZECH assocation of ayurvedic medicine
28.10.2007   Ayuvedic Industry-Opporunities in Germany Ms.Iris Huettner, Honorary representetive for ayurveda , German Wellness assocation
28.10.2007   India-EU partnership-Ayurvedic Industry Dr. Bruno Liebhaberg, MD BEE
28.10.2007   Ayurveda in Canada Dr.Rakesh Modi, Director ICAP Inc.
       
27TH to 29th June, 2007 Pharmexcil India – LAC International Pharma Conference  
27.06.2007   Shri D B Mody speech at
LAC meet - Eng
 
27.06.2007   Shri D B Mody speech at LAC meet - Spanish  
27.06.2007   Jamaica Regulatory Affairs Princess Thomas Osbourne, FDA
27.06.2007   Jamaica Registration Guidelines for Devices  
27.06.2007   Jamaica – Registration guidelines – Ethical Drugs  
27.06.2007   Jamaica-Registration Guidelines for Herbals  
27.06.2007   Jamaica-STATUTORY & Other basic REQUIREMENTS for dossiers  
27.06.2007   Jamaica - Pharma Market Mr. Guna Muppuri
27.06.2007   Trinidad & Tobago- drug requirements Mr.Deoraj Ramcharan, FDA
27.06.2007   Trinidad & Tobago - Bioequivalence Studies-1 Mr.Sham Bissessar, FDA
27.06.2007   Trinidad & Tobago -CHAPTER 30 F&D Act  
28.06.2007   Elsalvador-PRESENTACION I Dr.Roberto Rivas Amaya
28.06.2007   Elsalvador-PRESENTACION REGISTRO II Dr.Roberto Rivas Amaya
28.06.2007   Elsalvador- Requisitos registro medicamentos Dr.Roberto Rivas Amaya
28.06.2007   Brazil- -Health Ind. Opportunities Nelson Proenca
28.06.2007   Costa Rica- Registration Sandra Martinez Urbina
28.06.2007   1Honduras – Regulatory Affairs Dr.Osmin Padilla
28.06.2007   Mexico- Pharma Industry MS.Alejandra Holguin
28.06.2007   Latin American Countries – Pharmaceutical Markets Mr. Chriss Swann, M/s. Espicom Business Intelligence (could not be presented in person)
28.06.2007   Indian Pharma, Global Scenario Mr.PUM Rao, Govt., of India
28.06.2007   Drug Regulatory Process in LAC countries Dr. Milind Joshi, JB Chemicals
28.06.2007   DST-Govt., initiatives promoting R&D Dr.GJ.Samathanam
Govt., of India
28.06.2007   Biotechnology opportunities in AP, INDIA Mr.KRK.Reddy,
Govt., of A.P.
28.06.2007   Role of Indian Pharmacopoeia Commission Dr.GN.Singh-IPC,
Govt., of India
28.06.2007   Indian Biotech Sector Mr.Sandeep
M/s.Biocon Ltd.
28.06.2007   Herbals & Ayurvedics - Status Mr.Brijesh Kapil
M/s. Ranbaxy
28.06.2007   Global Opportunities for Indian Herbals.Ayurvedics Mr.Anurag Agarwal
M/s. Indian Herbals
28.06.2007   25. United States Pharmacopoeia Ms.Kumud Sampath
M/s.USP India
28.06.2007   Regulatory Frame work of ISM Products Mr.Shashank Sandu, ADMA
28.06.2007   Ayurveda Global opportunities & challenges Dr.HS.Palep, Expert
28.06.2007  

Drug product Approvals in Europe

Dr.Martin Slade
M/s. PharmAssess
   

 

June 19 2007 Pharmexcil Meeting

Pharma Export Procedure And Documentation

 
       
   

1.Custom Formalities For Export

Dr.Ishwar Singh

Joint Commissioner Of Customs,

Ahmedabad

   

2.Export Opportunities In Pharmaceutical Sector & The Role Of Pharmexcil

Dr.P.V.Appaji, Executive Director, Pharmexcil

   

3.Export Regulations Under FEMA

Smt. B. Rajagopal, Agm, Fed, Ahmedabad

   

4.Exim Bank Initiatives In Facilitating International Trade

Mr.Rikesh Chand

Resident Representative 

Export-Import Bank Of India, Ahmedabad Regional Office

   

5.Export Factoring & Forfeiting

Ms. Shruti Singh, Manager, Global Trade Finance Ltd.

   

6.Export Credit Insurance – Risk Coverage

Mr. S.M.Narvekar, Branch Manager, ECGC

       
    1. “The barriers/constraints in the Exports of ASU Products and Expectations of the Industry from Indian Govt.” Dr. Anantha Narayana D B
Head: Herbals Research,
Hindustan Lever Research Center
    2. Immediate Initiatives &
ASU in Foreign Trade Policy
2007-09

Dr. Ranjit Puranik, General Secretary, ADMA
    3. Study on Medicinal Plants Dr. Varun khanna, DGM, NCTI
    4. Proposed Certification Scheme on Herbal & Ayurvedic Products Ms. Shashi Sareen, Director,
Export Inspection Council of India, Ministry of Commerce & Industry
       
June 6 2007
Pharmexcil Meeting Roadmap for Promotion of Exports of Herbal / Ayurvedic Products  
May 12 2007 3rd Formation Day Welcome Speech by Chairman D.B.Mody, Chairman, Pharmexcil
    Global API Market (Indian Perspective) Arun Sawhney, President – Bulk Actives, Dr.Reddy’s Laboratories
    Generic Pharmaceuticals “Opportunities in Global Markets & How to meet them” Lanka Srinivas, Director, Aurobindo Pharma Ltd
    Approaching International Markets in Biogenerics Dr.K.I.Varaprasad Reddy, Managing Director, Shantha Biotechnics Ltd
    Effect of Counterfeit on Pharma Exports Dr.Milind Joshi, President – Global Regulatory Management, J.B.Chemicals & Pharmaceuticals Ltd
    Drugs Price Control Order and Recent Developments L.M.Kaushal, Director, National Pharmaceutical Pricing Authority
       
Apr 4 2007 Seminar on “Export Procedure & Documentation” at Bangalore Foreign Trade Policy 2004 – 2009 -- An Overview Jt. Director General of Foreign Trade, Bangalore
    Export Opportunities in Pharmaceutical Sector and the Role of Pharmexcil Dr. P.V.Appaji, Executive Director, Pharmexcil
    Customs Formalities for Export Jt. Commissioner of Customs, Bangalore
    Foreign Exchange Regulations for Exports General Manager, Reserve Bank of India, Bangalore
    Export Procedures Prasanna Srinivasan, FKCCI, Bangalore
       
Jan 24 2007 Shri.Anwarhul Hoda, Member-Planning Commission, Govt. of India Merits of Continuation with DEPB Scheme D.B.Mody, Chairman, Pharmexcil
       
   
 

Archives

 

Previous Years:

 
2006
2005
  *=For Members Only
   
Google
 
Pharmexcil 2004. All rights reserved.        
Powered by